| Ticker Details |
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$85.88B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.35 | 1.23%
|
| Avg Daily Range (30 D): |
$0.97 | 1.63%
|
| Avg Daily Range (90 D): |
$0.96 | 1.39%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.94M |
| Avg Daily Volume (30 D): |
14.98M |
| Avg Daily Volume (90 D): |
14.43M |
| Trade Size |
| Avg Trade Size (Sh.): |
241 |
| Avg Trade Size (Sh.) (30 D): |
100 |
| Avg Trade Size (Sh.) (90 D): |
94 |
| Institutional Trades |
| Total Institutional Trades: |
108,345 |
| Avg Institutional Trade: |
$3.44M |
| Avg Institutional Trade (30 D): |
$6.07M |
| Avg Institutional Trade (90 D): |
$7.04M |
| Avg Institutional Trade Volume: |
.11M |
| Avg Institutional Trades (Per Day): |
18 |
| Market Closing Trades |
| Avg Closing Trade: |
$30.17M |
| Avg Closing Trade (30 D): |
$133.47M |
| Avg Closing Trade (90 D): |
$147.48M |
| Avg Closing Volume: |
727.97K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$2.41
|
$.9
|
$.46
|
|
Diluted EPS
|
$2.39
|
$.9
|
$.45
|
|
Revenue
|
$20.62B
|
$5.2B
|
$5.29B
|
|
Gross Profit
|
$14.26B
|
$3.61B
|
$3.68B
|
|
Net Income / Loss
|
$3.56B
|
$1.34B
|
$670M
|
|
Operating Income / Loss
|
$3.79B
|
$1.1B
|
$825M
|
|
Cost of Revenue
|
$6.36B
|
$1.59B
|
$1.61B
|
|
Net Cash Flow
|
$725M
|
$-503M
|
$671M
|
|
PE Ratio
|
|
|
|
|
|
|
